Cargando…

A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy

PURPOSE: To identify candidate gene mutations to significantly predict the risk of survival prognosis after treatment with systemic first-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC) patients. MATERIALS AND METHODS: Between 2005 and 2017, 168 triplet-tissue block samples from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Han, Park, Jongkeun, Park, Weon Seo, Hong, Dongwan, Chung, Jinsoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643729/ https://www.ncbi.nlm.nih.gov/pubmed/36347549 http://dx.doi.org/10.4111/icu.20210341

Ejemplares similares

A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

OGT and FLAD1 Genes Had Significant Prognostic Roles in Progressive Pathogenesis in Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2023)

Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Analysis of the concordance of 20 immunohistochemical tissue markers in metastasectomy lesions in patients with metastatic renal cell carcinoma: A retrospective study using tissue microarray
por: Kim, Sung Han, et al.
Publicado: (2020)

Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study
por: Kim, Sung Han, et al.
Publicado: (2020)

Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma
por: Kim, Sung Han, et al.
Publicado: (2017)

Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray
por: Kim, Sung Han, et al.
Publicado: (2020)

Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison
por: Kim, Sung Han, et al.
Publicado: (2017)

SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change
por: Kim, Sung Han, et al.
Publicado: (2019)

Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis
por: Kim, Sung Han, et al.
Publicado: (2018)

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
por: Kim, Myung Soo, et al.
Publicado: (2018)

Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021)

A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2017)

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Single-Center Analysis of Human Papillomavirus Infection and P16INK4A Expression among Korean Patients with Penile Cancer
por: Kwon, Whi-An, et al.
Publicado: (2019)

Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
por: Park, Jae Young, et al.
Publicado: (2020)

The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry
por: Kim, Sung Han, et al.
Publicado: (2017)

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis
por: Kim, Sung Han, et al.
Publicado: (2019)

Systematic Guidelines for Effective Utilization of COVID-19 Databases in Genomic, Epidemiologic, and Clinical Research
por: Seong, Do Young, et al.
Publicado: (2023)

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
por: Procopio, G, et al.
Publicado: (2012)

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy
por: Kim, Sung Han, et al.
Publicado: (2019)

The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients
por: Cho, In-Chang, et al.
Publicado: (2015)

Metastatic renal carcinoma comprehensive prognostic system
por: Atzpodien, J, et al.
Publicado: (2003)

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

The De Ritis and Neutrophil-to-Lymphocyte Ratios May Aid in the Risk Assessment of Patients with Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2018)

Current Status of Targeted Therapy for Advanced Renal Cell Carcinoma
por: Cho, In-Chang, et al.
Publicado: (2012)

Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures
por: Lee, Jongkeun, et al.
Publicado: (2018)

A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma
por: Cho, Kang Su, et al.
Publicado: (2008)

Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy
por: Kim, Sung Han, et al.
Publicado: (2017)

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
por: Mihály, Z, et al.
Publicado: (2012)

Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study
por: Kim, Sung Han, et al.
Publicado: (2015)

A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients
por: Park, Jihye, et al.
Publicado: (2019)

Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens
por: Cho, In-Chang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ktn5fuutbq0jj7cvi6u4qs3lig